XML 81 R70.htm IDEA: XBRL DOCUMENT v3.10.0.1
Related-Party Transactions - Additional Information (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Oct. 31, 2017
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
Related Party Transaction [Line Items]            
Collaborative development services   $ 2,887,454 $ 302,411 $ 5,312,560 $ 302,411  
Accounts receivable   3,481,994   3,481,994   $ 6,356,268
Research and development   2,758,984 1,618,889 5,348,270 2,885,952  
Revenues   4,910,766 1,760,756 9,069,418 3,131,925  
SOW One            
Related Party Transaction [Line Items]            
Collaborative development services   1,078,418 277,400 2,397,136 277,400  
Profit sharing payments included in collaborative development services revenue   0   99,394    
Accounts receivable   429,019   429,019   2,429,152
Research and development   669,994 222,200 1,716,115 222,200  
SOW Two            
Related Party Transaction [Line Items]            
Collaborative development services   869,827   1,480,818    
Profit sharing payments included in collaborative development services revenue   0   386,369    
Accounts receivable   729,448   729,448   1,796,157
Research and development   420,876   764,142    
Costs     0   0  
Revenues     0   0  
SOW Three            
Related Party Transaction [Line Items]            
Collaborative development services   939,209   1,434,606    
Profit sharing payments included in collaborative development services revenue   0   0    
Accounts receivable   879,526   879,526   0
Research and development   627,709   $ 854,564    
Costs     0   0  
Revenues     0   0  
QIAGEN Manchester Limited            
Related Party Transaction [Line Items]            
Agreement commencement period       2016-11    
QIAGEN Manchester Limited | Maximum            
Related Party Transaction [Line Items]            
Term of Agreement       1 year    
QIAGEN North American Holdings, Inc. | Convertible Promissory Note            
Related Party Transaction [Line Items]            
Cash proceeds from issuance of subordinated notes $ 3,000,000          
Unamortized deferred financing costs   32,513   $ 32,513   $ 39,240
QIAGEN North American Holdings, Inc. | Convertible Promissory Note | Interest Expense            
Related Party Transaction [Line Items]            
Amortization of deferred financing costs   3,364 0 6,727 0  
Interest accrued   $ 22,438 $ 0 $ 44,630 $ 0